AGASTRA – LAB: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
AGASTRA – LAB
Largest movements
- Cash -€815
down €815 (-82.6%), from €986 to €171
mainly Net result for the year (-€4,478)
- Receivables within one year -€534
down €534 (-46.9%), from €1,140 to €606
- Profit (loss) carried forward -€4,478
down €4,478 (-6.2%), from -€72,245 to -€76,724
- Other debts +€2,879
up €2,879 (+5.5%), from €52,658 to €55,537
- Trade debts +€128
up €128 (+10.4%), from €1,226 to €1,353
- Accrued charges and deferred income +€123
up €123 (+454%), from €27 to €150
- Other operating charges +€400
up €400 (+266%), from €150 to €550
- Gross operating margin -€185
down €185 (-5.0%), from -€3,708 to -€3,894
- Financial income +€50
new in 2025: €50
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,126 | €777 | -€1,349 | -63.4% |
| Current assets | 29/58 | €2,126 | €777 | -€1,349 | -63.4% |
| Amounts receivable within one year | 40/41 | €1,140 | €606 | -€534 | -46.9% |
| Other amounts receivable | 41 | €1,140 | €606 | -€534 | -46.9% |
| Cash at bank and in hand | 54/58 | €986 | €171 | -€815 | -82.6% |
| Total equity and liabilities | 10/49 | €2,126 | €777 | -€1,349 | -63.4% |
| Equity | 10/15 | -€51,785 | -€56,264 | -€4,478 | -8.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Capital | 10 | €18,600 | €18,600 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Legal reserve | 130 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€72,245 | -€76,724 | -€4,478 | -6.2% |
| Amounts payable | 17/49 | €53,911 | €57,041 | +€3,129 | +5.8% |
| Amounts payable within one year | 42/48 | €53,884 | €56,891 | +€3,007 | +5.6% |
| Trade debts | 44 | €1,226 | €1,353 | +€128 | +10.4% |
| Suppliers | 440/4 | €1,226 | €1,353 | +€128 | +10.4% |
| Other amounts payable | 47/48 | €52,658 | €55,537 | +€2,879 | +5.5% |
| Accrued charges and deferred income | 492/3 | €27 | €150 | +€123 | +454% |
| Other operating charges | 640/8 | €150 | €550 | +€400 | +266% |
| Gross operating margin | 9900 | -€3,708 | -€3,894 | -€185 | -5.0% |
| Operating profit (loss) | 9901 | -€3,858 | -€4,443 | -€585 | -15.2% |
| Financial income | 75/76B | - | €50 | +€50 | |
| Recurring financial income | 75 | - | €50 | +€50 | |
| Financial charges | 65/66B | €80 | €85 | +€5 | +5.7% |
| Recurring financial charges | 65 | €80 | €85 | +€5 | +5.7% |
| Profit (loss) for the period before taxes | 9903 | -€3,939 | -€4,478 | -€540 | -13.7% |
| Profit (loss) for the period | 9904 | -€3,939 | -€4,478 | -€540 | -13.7% |
| Profit (loss) for the period to be appropriated | 9905 | -€3,939 | -€4,478 | -€540 | -13.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.